STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
QURE UNIQURE NV StockScouter® Report
2
StockScouter® Score
UNIQURE NV, a small cap growth company in the healthcare sector, is expected to slightly underperform the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The multi-period measure of relative price change and consistency is well above average. Positive
Concerns
- One or more analysts has significantly decreased quarterly earnings estimates for QURE. Negative
- The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
- Two or more executives, directors or major shareholders sold a small number of shares recently. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, growth stocks will be in favor, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
C
D
F
A